L. Tomei, “Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study”, IJPAI, vol. 36, no. 4, pp. 40–41, Jan. 2023.